Affiliation:
1. Lorestan University of Medical Sciences
2. Shahid Sadoughi University of Medical Sciences
3. Semnan University of Medical Sciences
4. Shahid Rahimi Hospital Lorestan University of Medical Sciences
Abstract
Abstract
Breast cancer is the first type of malignancy and the leading cause of cancer-related deaths in women worldwide. The purpose of this study is to investigate the epidemiology of breast cancer in Iran and its relationship with the human development index. The present study is a descriptive analytical study. Data related to the incidence, mortality, years of life with disability (YLDs), YLLs and DALYs of breast cancer in Iran were extracted from the World Burden of Disease 2019 website. Correlation tests are used to check the relationship between these indicators and the human development index. The highest incidence rate of breast cancer in 2019 is related to the provinces of Gilan (29 per 100,000) and Tehran (28.55 per 100,000) and the highest rate of death from breast cancer is related to the provinces of Gilan (10.71 per 100,000). and Semnan (9.97 in 100,000). The results showed that there is a positive and significant correlation between DALY (r = 0.626, P < 0.0001), YLL (r = 0.611, P < 0.0001) and YLD (r = 0.773, P < 0.0001) breast cancer with HDI index. There is a positive and significant correlation between the incidence (r = 0.794, P < 0.0001) and mortality (r = 0.503, P = 0.003) of breast cancer with the HDI index. Considering that the incidence and mortality rate of breast cancer in the country is increasing, in the fight against breast cancer, an appropriate strategy should be adopted with universal health coverage and, finally, approaches Screening and treatment of breast cancer can reduce the burden caused by this cancer in the country.
Publisher
Research Square Platform LLC
Reference47 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA: a cancer journal for clinicians,2021
2. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study;Heer E;The Lancet Global Health,2020
3. Global incidence and mortality of liver cancers and its relationship with the human development index (HDI): an ecology study in 2018;Goodarzi E;World Cancer Res J,2019
4. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases;Anderson BO;The Lancet Oncology,2021
5. Breast cancer epidemiology and risk factors;Rojas K;Clinical obstetrics and gynecology,2016